Download Free Sample Report

Menopause Drugs Market - Global Outlook and Forecast 2022-2028

Menopause Drugs Market - Global Outlook and Forecast 2022-2028

  • Published on : 15 July 2022
  • Pages :119
  • Report Code:SMR-7208846

Download Report PDF Instantly

Leave This Empty:

Secure

Report overview

Menopause?is the end of a woman?s menstrual cycles. The term can describe any of the changes you go through just before or after you stop having your period, marking the end of your reproductive years.
This report contains market size and forecasts of Menopause Drugs in global, including the following market information:
Global Menopause Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Menopause Drugs Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Menopause Drugs companies in 2021 (%)
The global Menopause Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Parenteral Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Menopause Drugs include Eli Lilly, Pfizer, AbbVie, Novo Nordisk, Merck KGaA, Mylan, Bayer, Teva and Novartis, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Menopause Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Menopause Drugs Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Menopause Drugs Market Segment Percentages, by Type, 2021 (%)
Parenteral
Transdermal
Oral
Others
Global Menopause Drugs Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Menopause Drugs Market Segment Percentages, by Application, 2021 (%)
Hospitals
Drugstores
Others
Global Menopause Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Menopause Drugs Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Menopause Drugs revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Menopause Drugs revenues share in global market, 2021 (%)
Key companies Menopause Drugs sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Menopause Drugs sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Eli Lilly
Pfizer
AbbVie
Novo Nordisk
Merck KGaA
Mylan
Bayer
Teva
Novartis
Abbott
Roche
Endo International
Ipsen
ANI Pharmaceuticals
TherapeuticsMD